Zhong, Jingqin
48  results:
Search for persons X
?
 
?
3

Survival impact of immediate complete lymph node dissection..:

Zhong, Jingqin ; Zou, Zijian ; Hu, Tu...
Clinical and Experimental Medicine.  23 (2023)  7 - p. 4003-4010 , 2023
 
?
 
?
5

Correction to: BRAF Inhibitor Resistance in Meslanoma: Mech..:

Zhong, Jingqin ; Yan, Wangjun ; Wang, Chunmeng...
Current Treatment Options in Oncology.  23 (2022)  12 - p. 1877-1878 , 2022
 
?
6

BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alter..:

Zhong, Jingqin ; Yan, Wangjun ; Wang, Chunmeng...
Current Treatment Options in Oncology.  23 (2022)  11 - p. 1503-1521 , 2022
 
?
8

Comparative analysis of adjuvant therapy for stage III BRAF..:

Zhong, Jingqin ; Sun, Wei ; Hu, Tu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242313/.  , 2023
 
?
9

Survival impact of immediate complete lymph node dissection..:

Zhong, Jingqin ; Zou, Zijian ; Hu, Tu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618307/.  , 2023
 
?
10

Delineating the early dissemination mechanisms of acral mel..:

Wei, Chuanyuan ; Sun, Wei ; Shen, Kangjie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10709603/.  , 2023
 
?
 
?
12

Application of Multi-Omics Approach in Sarcomas: A Tool for..:

Zou, Zijian ; Sun, Wei ; Xu, Yu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304858/.  , 2022
 
?
13

Clinical value of sentinel lymph node biopsy in patients wi..:

ZOU Zijian ; SUN Wei ; HU Tu...
http://www.china-oncology.com/fileup/1007-3639/PDF/1675314917012-784720088.pdf.  , 2022
 
?
14

BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alter..:

Chen, Yong ; Zhong, Jingqin ; Sun, Wei...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596525/.  , 2022
 
?
15

Multivariable prognostic analyses of Chinese acral and cuta..:

LIN Xinyi ; SUN Wei ; HU Tu...
http://www.china-oncology.com/fileup/1007-3639/PDF/1675314912970-560969330.pdf.  , 2022
 
1-15